T. Rowe Price Investment Management, Inc.

Position in ELAN — Elanco Animal Health Inc

CIK 1897612 BALTIMORE, MD

Back to ELAN Full portfolio

Position in ELAN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$707,555,194

-$121,262,413 QoQ

Shares Held

28,750,719

-17.0% QoQ

Ownership

5.75%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

of 518 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $764,720,816 across 2 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (92.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ELAN	Elanco Animal Health Inc This page	28,750,719	$707,555,194
2	ALKS	Alkermes plc.	1,090,947	$57,165,622

All Filings in ELAN

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$707,555,194	28,750,719	-17.0%	Shares	Sole	2026-08-14
2026-03-31	$828,817,607	34,635,086	+106.9%	Shares	Sole	2026-05-15
2025-12-31	$378,750,728	16,736,665	-46.9%	Shares	Sole	2026-02-17
2025-09-30	$634,611,681	31,510,014	+61.1%	Shares	Sole	2025-11-14
2025-06-30	$279,244,571	19,554,942	+22.3%	Shares	Sole	2025-08-14
2025-03-31	$167,825,605	15,983,391	+1.9%	Shares	Sole	2025-05-14
2024-12-31	$190,014,812	15,690,736	-25.4%	Shares	Sole	2025-02-14
2024-09-30	$309,118,820	21,042,806	+115.4%	Shares	Sole	2024-11-14
2024-06-30	$140,987,737	9,770,460	+4.5%	Shares	Sole	2024-08-14
2024-03-31	$152,195,419	9,348,613	+60.3%	Shares	Sole	2024-05-15
2023-12-31	$86,904,071	5,832,488	+152.5%	Shares	Sole	2024-02-14
2023-09-30	$25,958,847	2,309,506	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.